F2G’s hopes of getting the first in a brand-new class of antifungals to market have hit a setback courtesy of a complete response letter from the FDA. The regulator was due to make a call on approving ...

Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would have ...

A recent study published in the journal Biomedicines aimed to determine the antifungal tolerance of Candida auris (C. auris) to all three classes of antifungal drugs commonly used to treat invasive ...

In a Class I recall, the most serious type, a New Jersey drugmaker is removing 17,376 drug cartons from the market because of a cross-contamination risk. Scynexis is recalling two lots of Brexafemme ...

In late 2022, the World Health Organization released a list of 19 fungi that pose the greatest threat to public health. When we think about dangerous infectious diseases, drug-resistant bacteria or ...

In a recent study published in npj Antimicrobials and Resistance, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal ...

Fungal pathogens that live harmlessly on and inside the human body are increasingly defeating the limited arsenal of antifungal drugs, while simultaneously dodging the immune system’s surveillance.

As fungi resistant to traditional treatments continue to spread around the globe, researchers from China Pharmaceutical University in Nanjing have identified a bacterial compound that can kill ...

Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...